H-1B Under Pressure: Can Trump’s Fee Protect U.S. Jobs Without Hurting Innovation?
Imagine paying USD 100,000 fee just to bring in quality talent for a job with the H-1B program. That is…
Nvidia Bets USD 100 Billion on OpenAI’s Next Leap
Can Nvidia’s USD 100 Billion AI Investment Deliver Sustainable Profits? Nvidia (NASDAQ: NVDA) has just taken its most ambitious step…
Atlas Arteria (ASX:ALX): Meet the ASX’s other toll road operator – a company with no exposure to Australia
Atlas Arteria (ASX:ALX) is one of two toll road operators on the ASX, with the other being Transurban (ASX:TCL). But…
Bulls and Bears: Who are these investors and how do they invest their money?
You’ve likely heard of the term or terms ‘Bulls and Bears’ describing two different types of investor sentiment, and of…
St George Mining has surged from $50m to >$250m in just 5 months and its latest drilling results are spectacular!
St George Mining (ASX:SGQ) has had a spectacular few months capped off with its latest drilling results. Its Araxa Niobium-REE…
5 Different Types of Entertainment Stocks to Invest in
People love their entertainment, and they spend more money on it than ever before, whether it’s binge-watching shows on Netflix,…
Amplia Therapeutics (ASX:ATX): Battling pancreatic cancer with an FAK inhibitor
Amplia Therapeutics (ASX:ATX) is another ASX oncology biotech company, attempting to battle cancer. At first glance, it may not a…
Is another boom in ASX BNPL stocks brewing? And how would Mk. 2 differ from Mk. 1
Is a new era on the horizon for ASX BNPL stocks? After a boom that lasted from Afterpay’s May 2016…
Amazon Prime on Trial: FTC Says 40 Million Customers Misled
Amazon Faces Civil Trial Over Prime Membership Practices The world’s largest subscription program is under the microscope. Amazon (NASDAQ: AMZN),…
Yandal Resources Soars 60% on High-Grade Gold Discovery at Arrakis
Yandal Resources Unveils 54m Gold Hit at Arrakis, Shares Surge 60% Yandal Resources (ASX: YRL) has grabbed market attention with…
Starpharma (ASX: SPL) Soars 70% on Genentech Deal
Starpharma Lands Genentech Collaboration Starpharma (ASX: SPL) has caught investor attention with a stunning 70 percent share price surge after…
Vection Technologies (ASX: VR1) Surges 30% – What Sparked the Rally and What Comes Next?
Vection Technologies Soars on A$22 Million NATO Defence Deal — A Turning Point or Just a Spark? Vection Technologies (ASX:…
6 Trends on ASX Company Boards That Should Raise Investor Eyebrows
Last week, Ownership Matters released a major report on ASX Company Boards. The report, studied ASX 300 entities (excluding ‘stapled…
Intel (NDQ:INTC): Its been outmuscled by Nvidia, but its rival just became an investor by buying a US$5bn stake
Intel (NDQ:INTC) has a peculiar shareholder register that has included the US government (which bought 10% in August), Japan’s SoftBank…
Atlassian (NDQ:TEAM): Will this Aussie home grown tech company be made or broken by the AI boom?
Are Aussie investors really poorer for not having Atlassian (NDQ:TEAM) on the ASX? While many of the ASX’s tech stocks…